Kaletra Interactions
There are 781 drugs known to interact with Kaletra (lopinavir/ritonavir), along with 5 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 281 are major, 463 are moderate, and 37 are minor.
- View all 781 medications that may interact with Kaletra
- View Kaletra alcohol/food interactions (4)
- View Kaletra disease interactions (5)
Most frequently checked interactions
View interaction reports for Kaletra (lopinavir / ritonavir) and the medicines listed below.
- acyclovir
- albuterol
- amlodipine
- aspirin
- Atripla (efavirenz / emtricitabine / tenofovir)
- azithromycin
- clonazepam
- Combivir (lamivudine / zidovudine)
- Cymbalta (duloxetine)
- diazepam
- Epivir (lamivudine)
- fluconazole
- gabapentin
- ibuprofen
- Isentress (raltegravir)
- lamivudine
- Lipitor (atorvastatin)
- lisinopril
- Lyrica (pregabalin)
- melatonin
- metformin
- Nexium (esomeprazole)
- Norvir (ritonavir)
- oxycodone
- trazodone
- Truvada (emtricitabine / tenofovir)
- Viread (tenofovir)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- zidovudine
Kaletra alcohol/food interactions
There are 4 alcohol/food interactions with Kaletra (lopinavir / ritonavir).
Kaletra disease interactions
There are 5 disease interactions with Kaletra (lopinavir / ritonavir) which include:
Report options
QR code containing a link to this page
More about Kaletra (lopinavir / ritonavir)
- Kaletra consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: protease inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
